HomeORGANIZATION
ORGANIZATION

Tap Tax Cuts and AMED Subsidies, not Price Premium, to Fuel Innovation: JMA Chief
(Apr.7.2017)

JMA President Yoshitake Yokokura
The government should encourage innovation in the pharmaceutical industry through tax cuts and subsidies, instead of the current price-maintenance premium scheme, Japan Medical Association (JMA) President Yoshitake Yokokura stressed on April 6 ...
(LOG IN FOR FULL STORY)

News Calendar